SCHEMBL14925326

SCHEMBL14925326

CN(C)c1ncc(Br)nc1C#C[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10178153 0.83 — —
SCHEMBL15121116 0.79 — —
SCHEMBL14849815 0.79 — —
SCHEMBL422711 0.77 HTT (0.31) —
SCHEMBL10178307 0.77 — —
SCHEMBL10177493 0.77 — —
SCHEMBL29814797 0.77 HTT (0.31) —
SCHEMBL10109835 0.77 KDM4E (0.32) —
SCHEMBL14927221 0.76 — —
SCHEMBL28907220 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846917-B2 Compounds useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-30 — — US disclosed
US-8841337-B2 Compounds useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-23 — — US disclosed
US-20130115311-A1 Compounds Useful as Inhibitors of ATR Kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-09 — — US disclosed
US-20130115312-A1 Compounds Useful as Inhibitors of ATR Kinase VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-09 — — US disclosed
Send feedback